Sage Journals: Discover world-class research

Abstract

In 2009, the Department of Health and Human Services (DHHS) recommended initiating antiretroviral therapy (ART) for youth with HIV at higher CD4 counts (≤500 cells/mm³) than previously recommended (≤350 cells/mm³). Barriers experienced by providers regarding ART initiation in this population have not been assessed. From 12/2011–01/2012, we asked providers from the American Academy of HIV Medicine listserv who prescribed ART to youth (ages 13–25 years) with behaviorally-acquired HIV to complete a web-based survey. We presented a clinical vignette to explore potential barriers for initiating ART. Overall, 274/290 (94%) respondents completed the survey. Most felt confident that evidence supported initiating ART at higher CD4 counts (94%), and that benefits outweighed the risks of long-term toxicity (98%) or developing resistance (88%). Most (96%) initiated ART in the patient vignette (age 19 years, CD4 count ∼400). Patient characteristics (e.g., unstable housing or drug use) were perceived as large barriers to ART initiation. Low response rate (13%) was a limitation. Respondents were knowledgeable about relevant DHHS guidelines, believed sufficient evidence supported ART initiation at higher CD4 counts, and would provide treatment to those with CD4 counts ≤500cells/mm³. Understanding and overcoming barriers to initiation of ART perceived by providers is important to ensure implementation of ART treatment guidelines.

Get full access to this article

View all access options for this article.

References

Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. December 1, 2009; 1–161.

SurveyMonkey.com LLC.: Palo Alto, California www.surveymonkey.com. 2013 February 1.

http://www.hhs.gov/about/regionmap.html. 2013 February 1.

http://hab.hrsa.gov/abouthab/parta.html. 2013 February 1.

Lohse

, Hansen

, Pedersen

et al. Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med, 2007; 146:87–95.

, Armon

, Buchacz

, Wood

, Brooks

. Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure. J Acquir Immune Defic Syndr, 2009; 51:450–453.

Anis

, Nosyk

, Sun

et al. Quality of life of patients with advanced HIV/AIDS: Measuring the impact of both AIDS-defining events and non-AIDS serious adverse events. J Acquir Immune Defic Syndr, 2009; 51:631–639.

Harrison

, Song

, Zhang

. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr, 2010; 53:124–130.

Bhaskaran

, Hamouda

, Sannes

et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA, 2008; 300:51–59.

10.

Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies. Lancet, 2008; 372:293–299.

11.

Palella

FAC

, Buchacz

et al. CD4 at HAART initiation predicts long-term CD4 responses and mortality from AIDS and non-AIDS causes in the HIV outpatients study. In: 17th Annual Canadian Conference on HIV/AIDS Research. San Francisco, CA: CROI, 2010Abstract 9832010.

12.

Neuhaus

, Angus

, Kowalska

et al. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS., 2010; 24:697–706.

13.

Cohen

, Chen

, McCauley

et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med, 2011; 365:493–505.

14.

Kurth

, Mayer

, Beauchamp

et al. Clinician practices and attitudes regarding early antiretroviral therapy in the US. J Acquir Immune Defic Syndr, 2012; 61:e65–e69.

15.

McKeegan

, Rutstein

, Lowenthal

. Postnatal infant HIV prophylaxis: A survey of U.S. practice. AIDS Patient Care STDS, 2011; 25:1–4.

16.

White

, Mimiaga

, Krakower

, Mayer

. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS, 2012; 26:395–405.

17.

Myers

, Larson

, Cheng

et al. Hand hygiene among general practice dentists: A survey of knowledge, attitudes and practices. J Am Dent Assoc, 2008; 139:948–957.

18.

Cabana

, Flores

. The role of clinical practice guidelines in enhancing quality and reducing racial/ethnic disparities in paediatrics. Paediatr Respir Rev, 2002; 3:52–58.

19.

Garber

, Desai

, Zhou

et al. Barriers to adherence to cystic fibrosis infection control guidelines. Pediatr Pulmonol, 2008; 43:900–907.

20.

Cabana

, Rand

, Powe

et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA, 1999; 282:1458–1465.

21.

Hadland

, Milloy

, Kerr

et al. Young age predicts poor antiretroviral adherence and viral load suppression among injection drug users. AIDS Patient Care STDS, 2012; 26:274–280.

22.

Martinez

, Harper

, Carleton

et al. The impact of stigma on medication adherence among HIV-positive adolescent and young adult females and the moderating effects of coping and satisfaction with health care. AIDS Patient Care STDS., 2012; 26:108–115.

23.

Campsmith

, Rhodes

, Hall

, Green

. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acq Imm Def, 2010; 53:619–624.

24.

Hall

, Song

, Rhodes

et al. Estimation of HIV incidence in the United States. JAMA, 2008; 300:520–529.

25.

Mayer

. Introduction: Linkage, engagement, and retention in HIV care: Essential for optimal individual- and community-level outcomes in the era of highly active antiretroviral therapy. Clin Infect Dis, 2011; 52:S205–S207.

26.

Seekins

DSA

, Juday

, Stryker

, Das

. Barriers to accessing HIV testing, care, and treatment in the United States. Presented at XVIII International AIDS Conference, Vienna, Austria, 18–23 July 2010Abstract THPEO624.

Initiation of Antiretroviral Therapy in Youth with HIV: A U.S.-Based Provider Survey

Abstract

Get full access to this article

References